Wang Xiaoquan, Ilyushina Natalia A, Lugovtsev Vladimir Y, Bovin Nicolai V, Couzens Laura K, Gao Jin, Donnelly Raymond P, Eichelberger Maryna C, Wan Hongquan
Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Division of Biotechnology Research and Review II, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
J Virol. 2017 Jan 3;91(2). doi: 10.1128/JVI.01512-16. Print 2017 Jan 15.
Influenza A H3N2 variant [A(H3N2)v] viruses, which have caused human infections in the United States in recent years, originated from human seasonal H3N2 viruses that were introduced into North American swine in the mid-1990s, but they are antigenically distinct from both the ancestral and current circulating H3N2 strains. A reference A(H3N2)v virus, A/Minnesota/11/2010 (MN/10), and a seasonal H3N2 strain, A/Beijing/32/1992 (BJ/92), were chosen to determine the molecular basis for the antigenic difference between A(H3N2)v and the ancestral viruses. Viruses containing wild-type and mutant MN/10 or BJ/92 hemagglutinins (HAs) were constructed and probed for reactivity with ferret antisera against MN/10 and BJ/92 in hemagglutination inhibition assays. Among the amino acids that differ between the MN/10 and BJ/92 HAs, those in antigenic site A had little impact on the antigenic phenotype. Within antigenic site B, mutations at residues 156, 158, 189, and 193 of MN/10 HA to those in BJ/92 switched the MN/10 antigenic phenotype to that of BJ/92. Mutations at residues 156, 157, 158, 189, and 193 of BJ/92 HA to amino acids present in MN/10 were necessary for BJ/92 to become antigenically similar to MN/10. The HA amino acid substitutions responsible for switching the antigenic phenotype also impacted HA binding to sialyl receptors that are usually present in the human respiratory tract. Our study demonstrates that antigenic site B residues play a critical role in determining both the unique antigenic phenotype and receptor specificity of A(H3N2)v viruses, a finding that may facilitate future surveillance and risk assessment of novel influenza viruses.
Influenza A H3N2 variant [A(H3N2)v] viruses have caused hundreds of human infections in multiple states in the United States since 2009. Most cases have been children who had contact with swine in agricultural fairs. These viruses originated from human seasonal H3N2 viruses that were introduced into the U.S. swine population in the mid-1990s, but they are different from both these ancestral viruses and current circulating human seasonal H3N2 strains in terms of their antigenic characteristics as measured by hemagglutination inhibition (HI) assay. In this study, we identified amino acids in antigenic site B of the surface glycoprotein hemagglutinin (HA) that explain the antigenic difference between A(H3N2)v and the ancestral H3N2 strains. These amino acid mutations also alter binding to minor human-type glycans, suggesting that host adaptation may contribute to the selection of antigenically distinct H3N2 variants which pose a threat to public health.
甲型H3N2变异株[A(H3N2)v]病毒近年来在美国引发了人类感染,它起源于20世纪90年代中期传入北美猪群的人类季节性H3N2病毒,但在抗原性上与原始株及当前流行的H3N2毒株均不同。选择一株参考A(H3N2)v病毒A/明尼苏达/11/2010(MN/10)和一株季节性H3N2毒株A/北京/32/1992(BJ/92),以确定A(H3N2)v与原始病毒之间抗原性差异的分子基础。构建了含有野生型和突变型MN/10或BJ/92血凝素(HA)的病毒,并在血凝抑制试验中检测其与针对MN/10和BJ/92的雪貂抗血清的反应性。在MN/10和BJ/92 HA之间不同的氨基酸中,抗原位点A中的氨基酸对抗原表型影响很小。在抗原位点B内,MN/10 HA的第156、158、189和193位残基突变为BJ/92中的相应残基后,MN/10的抗原表型转变为BJ/92的抗原表型。BJ/92 HA的第156、157、158、189和193位残基突变为MN/10中存在的氨基酸是BJ/92在抗原性上变得与MN/10相似所必需的。导致抗原表型转变的HA氨基酸替换也影响了HA与通常存在于人类呼吸道中的唾液酸受体的结合。我们的研究表明,抗原位点B的残基在决定A(H3N2)v病毒独特的抗原表型和受体特异性方面起着关键作用,这一发现可能有助于未来对新型流感病毒的监测和风险评估。
自2009年以来,甲型H3N2变异株[A(H3N2)v]病毒在美国多个州引发了数百起人类感染。大多数病例是在农业展览会上接触过猪的儿童。这些病毒起源于20世纪90年代中期传入美国猪群的人类季节性H3N2病毒,但根据血凝抑制(HI)试验测量,它们在抗原特性方面与这些原始病毒和当前流行的人类季节性H3N2毒株均不同。在本研究中,我们确定了表面糖蛋白血凝素(HA)抗原位点B中的氨基酸,这些氨基酸解释了A(H3N2)v与原始H3N2毒株之间的抗原性差异。这些氨基酸突变也改变了与少量人类型聚糖的结合,表明宿主适应性可能有助于选择对公共卫生构成威胁的抗原性不同的H3N2变异株。